Executive Q&A: Daniel J. Huff on nuclear verdicts, medical malpractice defense and rising liability risks

Daniel J. Huff is a medical malpractice defense attorney and partner at Huff Powell Bailey. He has represented defendants in more than 120 jury trials, defending physicians across every medical specialty and numerous hospitals throughout Georgia. Over the past five years, he has tried more than 40 medical malpractice cases and is widely recognized for handling complex, high-exposure litigation. In 2024, Best Lawyers in America named him Georgia’s Medical Malpractice Defense Lawyer of the Year.

Daniel J. Huff

How do the claims you are defending today compare with those from 10 years ago?

In medical malpractice, the theories of liability — failure to diagnose and correctly treat — are still most common. Sexual assault claims have certainly increased in severity and posture in the past 10 years. Also, a decade ago, a catastrophic injury case might settle or verdict in the low seven figures; today, the same fact pattern can draw eight- or nine-figure demands before discovery even closes. The average of the top 50 medical malpractice verdicts rose from $32.6 million in 2022 to roughly $50 million in 2024, and 2025 saw one Utah birth injury verdict reach $951 million. Plaintiffs’ firms now research every case with focus groups to maximize awards.

What emerging legal or liability trend should health care executives be paying closer attention to in the next few years?

Nuclear verdicts are the headline, but the underlying driver executives should watch is settlement inflation in response to those verdicts. Increasingly, plaintiffs’ counsel frame specific cases around corporate liability themes, such as staffing decisions, understaffing and resource allocation rather than a single provider’s bedside judgment call. That changes a bedside malpractice case into a corporate negligence case, which pulls in broader discovery, corporate witnesses and bigger damages theories.

What are the most common mistakes health care organizations make after an adverse event that later complicates a malpractice case?

Documentation drift, where providers or risk managers add clarifying notes to the chart after the fact, allowing plaintiffs’ counsel to argue consciousness of guilt even when the intent was innocent; delayed or inconsistent internal incident reporting, which creates a record that looks different from what ends up in litigation; uncoordinated communication with the patient or family immediately after the event, either over-apologizing in a way that is construed as an admission or going silent, which damages the relationship and increases the odds of a claim being filed; failure to preserve equipment, monitoring strips or EHR audit trails promptly, creating spoliation exposure regardless of actual fault; and not looping in defense counsel early enough.

What separates organizations that consistently defend claims successfully from those that struggle?

The strongest defense outcomes trace back to habits formed long before litigation: consistent, contemporaneous documentation, a risk management team that treats every adverse event as a potential lawsuit and a culture where providers aren’t afraid to document uncertainty or differential diagnosis reasoning. Organizations that struggle tend to have fragmented communication between risk management, legal and clinical staff, and they often don’t have a relationship with defense counsel until the lawsuit is already filed, which means hindsight has invaded the story being prepared.

How has jury sentiment changed in recent years, and what does that mean for defense strategy? 

Juries generally distrust institutions and are more comfortable awarding large non-economic damages. The AMA has pointed to medical cost inflation, broader jury interpretations of non-economic damages and shifting jury attitudes as key drivers of rising verdicts. Anchoring tactics, including asking for enormous, specific dollar amounts early and often, are more effective than they used to be because jurors have less of an intuitive sense of what a reasonable award looks like. For defense counsel, this means adopting a more deliberate focus-group and research strategy, humanizing the provider, clearly grounding the standard-of-care arguments and accepting responsibility for the care provided.

What advice would you give to health care executives facing their first significant malpractice lawsuit?

Get defense counsel and your carrier involved immediately, resist the urge to investigate informally before counsel is engaged and trust the process of building the record methodically rather than reacting emotionally to the initial demand number, which is often intentionally inflated. Recognize that what determines the outcome happens in the first few months, in how evidence is preserved and how witnesses are prepared, not in the courtroom at the end.

If you could recommend one investment that would have the greatest impact on reducing malpractice risk, what would it be?

Investment in documentation infrastructure and training. So much of malpractice defense comes down to whether the chart shows that a provider considered the relevant differential diagnoses, weighed the risks and made a reasoned judgment call. When that reasoning is documented in real time, it’s one of the most powerful defense tools. When it’s absent, even objectively reasonable care can look indefensible in hindsight. Also, invest in early focus groups for legal cases with counsel. There is no better way to assess lawsuit risk.

Thanks to Our Digital Partners | Learn More Here